Inhibitor Therapeutics, Inc. (INTI) Total liabilities 2016–2021
Inhibitor Therapeutics, Inc. (INTI) total liabilities at each fiscal year-end, per SEC filings.
$3.7MFY2021 · since FY2016: $308,133 → $3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $3.7M | +5.4% |
| FY2020 | $3.5M | +1.8% |
| FY2019 | $3.4M | +185.8% |
| FY2018 | $1.2M | +99.6% |
| FY2017 | $601,489 | +95.2% |
| FY2016 | $308,133 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice